InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Velleca Mark A., Director. Officer active across 2 companies, notably G1 Therapeutics, Inc.. Aggregated, 14 filings have been logged. The latest transaction was disclosed on 17 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations14 total
€10,6675,542 shares@ €1.92470.0077% mcap57.5% of flow
Common Stock
SEC:0001415889-22-006741:0·
€7,8822,897 shares@ €2.72080.0057% mcap42.5% of flow
Common Stock
SEC:0001415889-22-003185:0·
€5,10715,000 shares@ €0.340514.7% of flow
Common Stock
SEC:0001562180-22-001223·
€5,10715,000 shares@ €0.34057.4% of flow
Common Stock
SEC:0001562180-22-001223:0·
€13,45840,000 shares@ €0.336538.8% of flow
Common Stock
SEC:0001562180-21-006964·
€13,45840,000 shares@ €0.336519.4% of flow
Common Stock
SEC:0001562180-21-006964:0·
€3,31210,000 shares@ €0.33129.6% of flow
Common Stock
SEC:0001562180-21-004949·
€3,31210,000 shares@ €0.33124.8% of flow
Common Stock
SEC:0001562180-21-004949:0·
€3,21610,000 shares@ €0.32169.3% of flow
Common Stock
SEC:0001562180-21-004348·
€3,21610,000 shares@ €0.32164.6% of flow
Common Stock
SEC:0001562180-21-004348:0·
€6,36820,000 shares@ €0.318418.4% of flow
Common Stock
SEC:0001562180-21-003737·
€6,36820,000 shares@ €0.31849.2% of flow
Common Stock
SEC:0001562180-21-003737:0·
€3,21110,000 shares@ €0.32119.3% of flow
Common Stock
SEC:0001562180-21-003460·
€3,21110,000 shares@ €0.32114.6% of flow
Common Stock
SEC:0001562180-21-003460:0·
14 of 14 declarations
About Velleca Mark A.
Mark A. Velleca is a director at G1 Therapeutics, Inc. and Black Diamond Therapeutics, Inc. In this role, he participates in the strategy and governance of these companies. With notable experience in the biopharmaceutical sector, Mark A. Velleca brings important skills to the board. His commitment to innovation and sustainability is essential for G1 Therapeutics and Black Diamond Therapeutics.
